CorMedix reported Q4 2024 net revenue of $31 million and FY 2024 revenue of $43 million, expecting $12 million adjusted EBITDA. CorMedix Inc. announced its preliminary unaudited financial results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback